Literature DB >> 29348396

A Case of Umbilical Artery Thrombosis in the Third Trimester of Pregnancy.

Fouad Lutfallah1, Nina Oufkir1, Georges A Markou1, Delphine Frimigacci1, Christophe Poncelet1,2.   

Abstract

BACKGROUND Umbilical artery thrombosis is an extremely rare complication during pregnancy. Umbilical artery thrombosis has a poor prognosis and is associated with increased rates of perinatal morbidity, including intrauterine growth restriction (IUGR), and fetal mortality. CASE REPORT We report a rare case of umbilical artery thrombosis, diagnosed by ultrasound, at 33 weeks gestation in a 30-year-old woman who had previously had an uneventful pregnancy. CONCLUSIONS Umbilical artery thrombosis is a rare complication of pregnancy that is associated with high fetal mortality. Management may include planned elective delivery by cesarean section, following antenatal corticosteroid therapy for fetal lung maturation.

Entities:  

Mesh:

Year:  2018        PMID: 29348396      PMCID: PMC5785950          DOI: 10.12659/ajcr.906859

Source DB:  PubMed          Journal:  Am J Case Rep        ISSN: 1941-5923


Background

Thrombosis of the umbilical artery is associated with increased rates of perinatal morbidity, including intrauterine growth restriction (IUGR), and increased fetal mortality [1-3]. Only a few cases of single arterial umbilical cord thrombosis have been described, and although the mechanism of occurrence is unclear, there are often associated additional cord abnormalities [4]. Previous studies have suggested that cord abnormalities could induce stasis of blood flow thrombosis formation [5]. A rare case of umbilical artery thrombosis is reported, which was diagnosed by ultrasound at 33 weeks of fetal gestation.

Case Report

A 30-year-old, multiparous, gravida 3 woman at 33 weeks and 2 days of gestation was referred to our center with a presumptive diagnosis of umbilical artery thrombosis. She had a history of two previous early spontaneous miscarriages. This pregnancy had been previously uneventful. There were no abnormalities found on the routine first and the second-trimester ultrasound (US) scans. The estimated fetal weight (EFW) was concordant with gestational age (70th centile). Three umbilical vessels were seen during the second US scan. At 33 weeks and 2 days of gestation, during the routine third-trimester US scan, a single right umbilical artery was observed. On the left side of the umbilical cord, a hyperechoic segment was seen. Uterine and umbilical artery Doppler flow imaging did not show any abnormality of blood flow. There was no evidence of fetal intrauterine growth restriction (IUGR) and no reduction in amniotic fluid volume. Fetal heart rate monitoring, maternal blood pressure, and maternal blood tests were normal. Because of the suspicion of umbilical artery thrombosis, the patient was admitted to hospital to ensure close follow-up. Antenatal corticosteroid therapy for fetal lung maturation was administered. Fetal heart rate remained normal during monitoring three times a day. A planned elective delivery by cesarean section was performed at 34 weeks and 3 days gestation and under spinal anesthesia. A healthy male infant was delivered with normal measurements, including a weight of 2,045 gm (25th centile), and with an Apgar score of 9 at the first and fifth minute. Arterial umbilical cord gases showed a pH of 7.31 and a lactate level of 2.0. Following delivery, macroscopic examination showed that the umbilical cord was normally inserted into a ‘placenta bipartite,’ but the umbilical cord was elongated, highly coiled and with a brownish color suggesting necrosis (Figure 1). The hypercoiled placenta contained ten coils for a 15 cm length cord and contained thrombus within an umbilical artery at 7 cm from the cord insertion into the placenta.
Figure 1.

Umbilical artery thrombosis and elective cesarean section at 34 weeks and 4 days. (A) Single umbilical artery blood flow imaged using Doppler ultrasound at the level of the bladder. (B) Thrombosis of the umbilical artery (arrow). There is a hyperechoic area within the umbilical artery. (C) Three vessels are seen within a brownish umbilical cord following delivery. A single umbilical artery is not present. (D) A highly coiled umbilical cord, which could explain the thrombotic event.

Histology of the umbilical cord and placenta showed a recent umbilical artery occlusion with thrombus that contained fibrin. Three months following delivery, full maternal thrombophilia screening tests were normal.

Discussion

During pregnancy, umbilical artery and umbilical vein thrombosis have rarely been reported. The incidence of umbilical cord thrombosis has been reported to occur in approximately 1/1300 deliveries, 1/1000 post-natal autopsies, and 1/250 high-risk gestations, respectively [6]. Venous, venous and arterial, and arterial thrombosis have been reported to occur in 70%, 20%, and 10% of cases, respectively [4]. Umbilical artery thrombosis has a poorer prognosis than umbilical venous thrombosis and has been associated with increased rates of perinatal morbidity, including intrauterine growth restriction (IUGR), and increased fetal mortality. Since umbilical artery thrombosis is rare, no clear data exist regarding the management of patients with this condition. The etiology of umbilical vessel thrombosis may be understood through Virchow’s triad of reduced blood flow, hypercoagulability, and vascular abnormality. Hypercoagulability may be associated with inherited or acquired, maternal or fetal, thrombophilia. Endothelial damage may be due to maternofetal infection (funisitis) or meconium-induced vascular necrosis. Blood stasis in vessels may be caused by mechanical or anatomical obstruction such as knots in the cord, hyper-coiling (antenatal umbilical cord index above 0.6), amniotic bands, velamentous cord insertion, and fetal vascular ectasia [1,3]. Maternal diabetes mellitus has been proposed as a risk factor for umbilical cord vascular thrombosis by some authors [1,7]. However, as in this case, there may be no clear underlying pathology. Clinical findings of umbilical artery thrombosis have been reported to include single umbilical artery or a fetal thrombotic vasculopathy, where the thrombus migrates towards the placenta [1,5]. The latter condition may result in fetal growth restriction, fetal intolerance to labor (fetal distress), perinatal encephalopathy and neurologic impairment, neonatal liver disease, as well as an increased risk of stillbirth. Therefore, it is important to check for umbilical artery thrombosis in the work-up for causes of IUGR. Because there is normally a single umbilical vein that carries oxygenated blood to the fetus, and two umbilical arteries that carry deoxygenated blood from the fetus, complete thrombosis of the umbilical vein can be lethal for the fetus [2]. However, small thrombi can migrate in the fetal circulation and cause cerebral or renal infarcts or end-organ lesions, such as amputation of the digits. In contrast to venous thrombosis, there is only partial necrosis of the vascular wall in umbilical artery thrombosis, as umbilical arteries lack vasa vasorum and their oxygen supply to the intima is provided by blood flow, and to the outer layer, this is provided by amniotic fluid [1,4]. Hyrtl’s anastomosis, which is present in 90% of placentas, connects the two umbilical arteries and can explain some of the clinical outcomes of umbilical artery thrombosis, including the prevention of placental hypoxia and infarctions [1,7]. In this reported case, no Hyrtl’s anastomosis was found on placental histologic examination. In this case, umbilical artery thrombosis may have been caused by an elongated and hypercoiled umbilical cord. The favorable course for the mother and child were due to early diagnosis, close maternal and fetal monitoring, and early delivery.

Conclusions

In cases of umbilical artery thrombosis in pregnancy, time and mode of delivery should take into account fetal morbidity associated with prematurity, possible fetal intolerance to labor (fetal distress), and the risks of a sudden adverse event. Therefore, the management of umbilical artery thrombosis may include planned elective delivery by cesarean section following antenatal corticosteroid therapy for fetal lung maturation.
  7 in total

1.  Umbilical arterial thrombosis with vascular wall necrosis: clinicopathologic findings of 11 cases.

Authors:  Y Sato; K Benirschke
Journal:  Placenta       Date:  2005-08-22       Impact factor: 3.481

2.  Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy.

Authors:  Raymond W Redline
Journal:  Hum Pathol       Date:  2004-12       Impact factor: 3.466

3.  Thrombosis of the umbilical vessels revisited. An observational study of 317 consecutive autopsies at a single institution.

Authors:  Laura Avagliano; Anna Maria Marconi; Massimo Candiani; Antonino Barbera; Gaetano Bulfamante
Journal:  Hum Pathol       Date:  2010-03-17       Impact factor: 3.466

Review 4.  Thrombosis of the umbilical cord: analysis of 52 cases and literature review.

Authors:  S A Heifetz
Journal:  Pediatr Pathol       Date:  1988

5.  Spontaneous intrauterine umbilical artery thrombosis leading to severe fetal growth restriction.

Authors:  P Klaritsch; M Haeusler; E Karpf; D Schlembach; U Lang
Journal:  Placenta       Date:  2008-03-04       Impact factor: 3.481

Review 6.  Ultrasound diagnosis and management of umbilical cord abnormalities.

Authors:  Junichi Hasegawa; Ryu Matsuoka; Kiyotake Ichizuka; Akihiko Sekizawa; Takashi Okai
Journal:  Taiwan J Obstet Gynecol       Date:  2009-03       Impact factor: 1.705

7.  Umbilical vein thrombosis: to deliver or not to deliver at the time of diagnosis?

Authors:  Chloé Dussaux; Olivier Picone; Guillemette Chambon; Mikael Tassin; Jelena Martinovic; Alexandra Benachi; Anne-Gaël Cordier
Journal:  Clin Case Rep       Date:  2014-11-17
  7 in total
  1 in total

1.  Consecutive chorioangiomas in the same pregnancy: A clinical case and review of literature.

Authors:  Chiara Germano; Eleonora Pilloni; Alessandro Rolfo; Giovanni Botta; Giulia Parpinel; Paolo Cortese; Ilenia Cotrino; Rossella Attini; Alberto Revelli; Bianca Masturzo
Journal:  Health Sci Rep       Date:  2022-04-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.